Syntaxin 4 Expression in Pancreatic β-Cells Promotes Islet Function and Protects Functional β-Cell Mass

Area of Science:

• Endocrinology
• Immunology
• Molecular Biology

Background:

• Syntaxin 4 (Stx4) is implicated in islet graft success for diabetes reversal.
• The precise molecular mechanisms of Stx4's protective effects are not fully understood.

Purpose of the Study:

• To investigate the role of Stx4 in protecting pancreatic beta-cells against inflammatory stress and diabetes.
• To elucidate the molecular pathways involved in Stx4-mediated beta-cell protection.

Main Methods:

• Utilized inducible transgenic mice overexpressing Stx4 in beta-cells (βTG-Stx4) and Stx4 heterozygous knockout mice.
• Challenged mice and human islets with streptozotocin (STZ) and proinflammatory cytokines in vitro and in vivo.
• Assessed beta-cell mass, glucose tolerance, insulin secretion, apoptosis, and NF-κB signaling.

Main Results:

• βTG-Stx4 mice showed resistance to STZ-induced hyperglycemia, beta-cell loss, and glucose intolerance.
• Stx4 overexpression enhanced insulin secretion and conferred resilience against cytokine-induced apoptosis in human islets.
• Stx4 overexpression reduced pro-inflammatory gene expression (CXCL9, CXCL10, CXCL11) and NF-κB activation.

Conclusions:

• Syntaxin 4 plays a critical protective role in pancreatic beta-cells against inflammatory damage and diabetes.
• Elevating Stx4 levels enhances beta-cell function, insulin secretion, and survival.
• Targeting Stx4 represents a promising therapeutic approach for managing diabetes and improving islet transplantation outcomes.